CompletedNCT00015340
Buprenorphine and naloxone for heroin dependence
About this title
Read the official source — NCT00015340Medication studyAges 18–59United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 59 years.
- Listed locations
- Los Angeles and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 1999
- Recruitment status
- Completed
- Enrollment listed in the registry
- 582
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 59 Years
- Official registry ID
- NCT00015340
- Official title
Show the full official title
Buprenorphine/Nx Treatment of Heroin Dependence-A Compassionate Use Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles · Tampa · Hines
2 more locations
- New York
- Seattle
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine/naloxone.
Who was this study for?
Listed age limits: 18 years to 59 years.
